Maravai LifeSciences Director Gifts 89k Shares; No Market Sale

Rhea-AI Filing Summary

Maravai LifeSciences Holdings, Inc. (MRVI) – Form 4 insider filing dated 07/11/2025

Director Gregory T. Lucier reported an internal reclassification of ownership that occurred on 07/10/2025. The transaction was coded “G,” indicating a gift rather than an open-market sale or purchase.

• Securities involved: 89,139 Class A common shares.
• From → To: Shares transferred from direct ownership to an indirect family partnership.
• Post-transfer holdings: 55,123 shares remain in Lucier’s direct account; 109,784 shares are now held indirectly via the family partnership.
• Consideration: $0; no cash changed hands.

The footnote clarifies that Lucier disclaims beneficial ownership except for his pecuniary interest. The spouse is general partner of the family partnership, which now exercises voting and dispositive power over the transferred shares.

No derivative securities were reported. Because the event is a non-monetary, insider-to-family transfer, it does not alter the company’s share count, earnings outlook, or insider net exposure. It mainly reflects personal estate or tax planning and carries minimal direct market impact.

Insights

Securities Analyst

TL;DR: Gifted shares; no market sale—neutral for MRVI investors.

The Form 4 shows an internal shift of 89,139 shares from Gregory Lucier’s direct ownership to a family partnership. Transaction code “G” and $0 price confirm a bona-fide gift, not a disposition for cash. Lucier’s aggregate equity exposure remains unchanged, so there is no dilution or signaling of bearish sentiment. Such transfers are common for estate planning and have negligible trading impact. Volume is modest (≈0.06 % of MRVI’s ~142 m shares outstanding), further supporting a neutral assessment.

Corporate Governance Expert

TL;DR: Governance-neutral estate move; ownership remains aligned with shareholders.

The gifting transaction keeps Lucier’s economic interest intact while shifting voting control to a related entity managed by his spouse. This maintains insider alignment yet slightly reduces direct accountability. No red flags arise because the transfer is transparent, carries no consideration, and Lucier explicitly disclaims beneficial ownership beyond his pecuniary stake. From a governance standpoint, the action is routine and not materially impactful for outside investors.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LUCIER GREGORY T

(Last) (First) (Middle)

C/O MARAVAI LIFESCIENCES HOLDINGS, INC.

10770 WATERIDGE CIRCLE, SUITE 200

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARAVAI LIFESCIENCES HOLDINGS, INC. [ MRVI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	07/10/2025		G		89,139(1)	D	$0	55,123	D
Class A Common Stock	07/10/2025		G		89,139(1)	A	$0	109,784	I	By Family Partnership

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose.

Remarks:

	/s/ Kurt Oreshack, by power of attorney for Gregory T. Lucier	07/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MRVI director Gregory T. Lucier report in the July 2025 Form 4?

He gifted 89,139 Class A shares to a family partnership at no cost on 07/10/2025.

Did Lucier sell any Maravai shares on the open market?

No. The Form 4 lists a gift transaction (code “G”) with a $0 price—there was no market sale.

How many MRVI shares does Lucier own after the transfer?

He directly holds 55,123 shares and indirectly holds 109,784 through the family partnership.

Does the transaction affect Maravai’s share count or earnings?

No. The gift is internal and cash-free; it does not change shares outstanding or financial results.

Why are insider gift transactions disclosed?

SEC rules require insiders to report any change in beneficial ownership, including gifts for estate or tax planning.